Home / Health / Epilepsy Patients Achieve Seizure Freedom After 12-Month Medication Adjustment

Epilepsy Patients Achieve Seizure Freedom After 12-Month Medication Adjustment

Summary

  • 60% of focal epilepsy patients become seizure-free after 12 months on medication
  • Patients with history of anxiety/depression more likely to have drug-resistant epilepsy
  • Levetiracetam only effective for 25% of patients as first-line treatment

According to a study published on August 25, 2025 in JAMA Neurology, it takes about a year for most people with focal epilepsy to find relief from anti-seizure medications. The research, conducted between 2012 and 2020, tracked nearly 450 newly diagnosed epilepsy patients across 34 centers in the U.S., Europe, and Australia.

The findings reveal that 60% of these patients were able to achieve complete seizure freedom after a median of 12 months on medication. However, 63% experienced ongoing or worsening seizures during their first year of treatment as doctors worked to find the right drug and dosage. Notably, those with a history of psychological issues like anxiety or depression were nearly twice as likely to have drug-resistant epilepsy that did not respond well to treatment.

The study also suggests that the common first-line medication, levetiracetam, may not be the most effective option. Only 25% of patients initially prescribed levetiracetam were able to become seizure-free on their first try. Despite these challenges, the researchers say the current arsenal of epilepsy drugs remains potent, with 84% of those who achieved seizure freedom never experiencing a relapse.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

According to the study, it takes a median of 12 months for focal epilepsy patients to achieve seizure freedom through anti-seizure medications.
The study found that patients with a history of psychological problems like anxiety or depression were nearly twice as likely to have drug-resistant epilepsy that did not respond well to treatment.
The study suggests that levetiracetam, a common first-line medication, may not be the most effective option, as only 25% of patients initially prescribed it were able to become seizure-free on their first try.

Read more news on